Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Circulating Tumor HPV DNA Kinetics for Squamous Cell Carcinoma of the Lacrimal Sac Treated with Chemoradiotherapy | Synapse
March 3, 2026
Open Access
Circulating Tumor HPV DNA Kinetics for Squamous Cell Carcinoma of the Lacrimal Sac Treated with Chemoradiotherapy
JP
Jonathan J. Paly
Massachusetts Eye and Ear Infirmary
WF
W. Faquin
Massachusetts Eye and Ear Infirmary
RM
Ross D. Merkin
Massachusetts Eye and Ear Infirmary
See all
Key Points
Circulating tumor HPV DNA levels significantly correlate with treatment response in patients.
Monitoring HPV DNA kinetics can provide valuable insights into disease progression and treatment success.
Assessment using chemoradiotherapy and HPV DNA tracking was utilized to evaluate tumor response.
Findings highlight the importance of HPV DNA as a potential biomarker in oncology for this cancer type.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Paly et al. (Fri,) studied this question.
synapsesocial.com/papers/69a75efec6e9836116a2a0d4
https://doi.org/https://doi.org/10.1007/s12105-026-01887-2